Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients

American Heart Journal
Philippe BerdaguéJean-Luc Reny

Abstract

B-type peptide assay (brain natriuretic peptide [BNP] and N-terminal prohormone brain natriuretic peptide [NT-proBNP]) is useful for the diagnosis of heart failure (HF), but few data are available on the use of these markers in elderly subjects. The aim of this study was to evaluate NT-proBNP assay for the diagnosis of acute left HF in patients older than 70 years hospitalized for acute dyspnea. We prospectively enrolled 256 elderly patients with acute dyspnea. They were categorized by 2 cardiologists unaware of NT-proBNP values into a cardiac dyspnea subgroup (left HF) and a noncardiac dyspnea subgroup (all other causes). Mean age was 81 +/- 7 years, and 52% of the patients were women. The diagnoses made in the emergency setting were incorrect or uncertain in 45% of cases. The median NT-proBNP value was higher (P < .0001) in patients with cardiac dyspnea (n = 142; 7906 pg/mL) than in patients with noncardiac dyspnea (n = 112; 1066 pg/mL). The area under the receiver operating characteristic curve was 0.86 (95% CI 0.81-0.91). At a cutoff of 2000 pg/mL, NT-proBNP had a sensitivity of 86%, a specificity of 71%, and an overall accuracy of 80% for cardiac dyspnea. The use of 2 cutoffs (< 1200 and > 4500 pg/mL) resulted in an 8% err...Continue Reading

References

Jul 1, 1993·Journal of General Internal Medicine·C D MulrowL E Farnett
Nov 21, 1997·Journal of Internal Medicine·T WallénK Nakao
Jul 19, 2002·The New England Journal of Medicine·Alan S MaiselUNKNOWN Breathing Not Properly Multinational Study Investigators
Mar 4, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Peter A McCulloughUNKNOWN Breathing Not Properly Multinational Study Investigators
Jun 25, 2003·Circulation·Thomas J WangRamachandran S Vasan
Aug 2, 2003·Lancet·James A de LemosMark H Drazner
Aug 19, 2003·European Journal of Heart Failure·Denis Mariano-GoulartPierre-Olivier Kotzki
Oct 27, 2004·Intensive Care Medicine·Patrick RayUNKNOWN EPIDASA Study Group

❮ Previous
Next ❯

Citations

Mar 9, 2007·Heart Failure Reviews·Michael A Burke, William G Cotts
May 15, 2007·BMC Cardiovascular Disorders·Stéphane JorgePatrick Ray
Jul 31, 2008·QJM : Monthly Journal of the Association of Physicians·P RayC Chenevier-Gobeaux
Dec 10, 2013·Journal of the American Medical Directors Association·Monica CombaMario Bo
Jun 7, 2008·The American Journal of Emergency Medicine·Camille Chenevier-GobeauxPatrick Ray
Jun 25, 2008·Clinical Biochemistry·Camille Chenevier-GobeauxPatrick Ray
Oct 30, 2007·International Journal of Cardiology·Frans H Rutten, Arno W Hoes
Sep 26, 2007·Respiratory Medicine·Ralf-Harto HübnerBurkhard Bewig
Nov 22, 2012·The American Journal of Cardiology·Luis V PaivaAntónio L Marques
Feb 26, 2016·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Jennifer L MartindaleRichard Sinert
Dec 19, 2017·European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine·Walter RenierFrank Buntinx
Jul 17, 2007·Circulation·W H Wilson TangUNKNOWN National Academy of Clinical Biochemistry Laboratory Medicine
Oct 13, 2010·Circulation·Neal L WeintraubUNKNOWN American Heart Association Council on Clinical Cardiology and Council on Cardiopulmonary, Critical Care, Perioperative and R
Jan 29, 2019·European Journal of Heart Failure·Emanuele PivettaUNKNOWN Study Group on Lung Ultrasound from the Molinette and Careggi Hospitals

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.